Clinics and Epidemiology of Pituitary Diseases in Modena Area Population
NCT05601141 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2025-03-14
Summary
This is an observational, longitudinal, single-center study.
The study is divided in two phases:
* FIRST PHASE (retrospective): registration of all patients affected by pituitary disorders followed at the Unit of Endocrinology of Azienda Ospedaliero-Universitaria of Modena
* SECOND PHASE (prospective): enrollment of all patients affected by pituitary disorders who attend the Unit of Endocrinology of the Azienda Ospedaliero-Universitaria of Modena.
An anonymized database will be created to collect the data of the patients. In particular, the data collected for each patient will include: personal data, data relating to pituitary pathology, symptoms at diagnosis, physical examination, radiological imaging, visual field data, data on surgical intervention, data on histological examination, biohumoral examinations, hormone tests, densitometric data, data on replacement therapies, medical therapies or other pharmacological therapies, data on comorbidities.
Conditions
- Pituitary
Sponsors & Collaborators
-
Azienda Ospedaliero-Universitaria di Modena
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-24
- Primary Completion
- 2031-10-24
- Completion
- 2031-10-24
Countries
- Italy
Study Locations
More Related Trials
-
AP Metabolism Transcriptomics
NCT06814314 ·Status: RECRUITING
-
Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After Treatment
NCT00699530 ·Status: WITHDRAWN
-
Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
NCT06635629 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Metyrapone in Patients With Hypercortisolism
NCT05255900 ·Status: COMPLETED
-
PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics
NCT05033119 ·Status: COMPLETED
-
Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease
NCT02697734 ·Status: COMPLETED ·Phase: PHASE3
-
Antipsychotics and Metabolic Syndrome
NCT00636753 ·Status: SUSPENDED
-
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
NCT04897802 ·Status: COMPLETED ·Phase: PHASE4
-
Circadian Clocks and Eating Patterns (Cohort)
NCT04642534 ·Status: COMPLETED
-
Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage
NCT01783717 ·Status: UNKNOWN ·Phase: NA
-
Osilodrostat Therapy and 11C-methionine PET to Improve Corticotroph Adenoma Detection
NCT06701838 ·Status: NOT_YET_RECRUITING
-
An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy
NCT00677313 ·Status: COMPLETED ·Phase: NA
-
Monitoring and Management for Metabolic Side Effects of Antipsychotics
NCT01875861 ·Status: COMPLETED ·Phase: NA
-
Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome
NCT07247162 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
NCT03038308 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Mindfulness Therapy in Patients With Acromegaly and Cushing
NCT04420000 ·Status: COMPLETED ·Phase: NA
-
Collecting Information About Treatment Results for Patients With Cushing's Syndrome
NCT03364803 ·Status: RECRUITING
-
Effects of Hyperprolactinemia Induced by Antipsychotic Drugs on Bone Metabolism
NCT03675750 ·Status: UNKNOWN
-
Long-term Beneficial Metabolic Effects of Adrenalectomy in Subclinical Cushing's Syndrome of Adrenal Incidentaloma
NCT01382420 ·Status: UNKNOWN ·Phase: NA
-
Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids
NCT03023891 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment
NCT06326840 ·Status: COMPLETED ·Phase: NA
-
Influence of Dopaminergic Blockade on Stress Responses, Motivation and Emotional Reactivity in Humans.
NCT03863691 ·Status: COMPLETED ·Phase: NA
-
Antipsychotic Medicine and Metabolic Syndrome
NCT00627757 ·Status: UNKNOWN
-
A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.
NCT03277690 ·Status: COMPLETED ·Phase: PHASE3
-
Does Serum-DXM Increase Diagnostic Accuracy of the Overnight DXM Suppression Test in the Work-up of Cushing's Syndrome?
NCT01504555 ·Status: UNKNOWN